NRC Health Q4 revenue rises 2%, TRCV up 8%

-0.22%

National Research Corporation

NRC

13.41

-0.22%

Overview

Healthcare solutions firm's Q4 revenue rose 2% qtr/qtr to $35.2 mln
Adjusted EPS for Q4 was $0.16
Total Recurring Contract Value (TRCV) increased 8% yr/yr to $144.1 mln, growing sequentially for fifth consecutive quarter

Outlook

Company did not provide specific guidance for future quarters or full year

Result Drivers

TRCV GROWTH - Total Recurring Contract Value increased 8% year-over-year to $144.1 million, marking the fifth consecutive quarter of sequential growth
CASH FLOW INCREASE - Cash flow from operations rose 13% year-over-year to $7.2 million

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Revenue		$35.19 mln
Q4 Adjusted EPS		$0.16
Q4 Net Income		$1.80 mln

Press Release: ID:nBwb5SxPda

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.